Fenwick & West advised Sema4 on the deal. Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, announced its agreement to acquire GeneDx, an […]
Sema4’s Acquisition of GeneDx
Castlight Health’s $370 Million Combination with Vera Whole Health
Fenwick & West advised Castlight Health on the deal, while Kirkland & Ellis advised Vera Whole Health. Castlight Health (NYSE: CSLT), a leading healthcare data and […]
Remitly’s $522.9 Million IPO
Fenwick & West advised Remitly on the deal. Davis Polk advised several underwriters on the deal. Remitly Global, Inc. (Nasdaq: RELY), a mobile-first provider of remittances […]
EngageSmart’s $378 Million IPO
Latham & Watkins represented EngageSmart, while Fenwick & West advised the underwriters on the deal. EngageSmart (NYSE: ESMT) announced its initial public offering. The company is a leading […]
Limelight’s $55 Million Acquisition of Layer0
Fenwick & West advised Moov Corporation (Layer0) on the deal while Goodwin Procter represented Limelight Networks, Inc. Limelight Networks, Inc. (Nasdaq: LLNW), a leading provider of […]
BuzzFeed’s Combination Agreement with 890 Fifth Avenue Partners SPAC
Fenwick & West LLP and Orrick advised BuzzFeed on the deal while Akin Gump Strauss Hauer & Feld LLP represented 890 5th Avenue Partners, Inc. BuzzFeed, […]
Cisco Systems’ Acquisition of Sedona Systems
Fenwick & West LLP advised Cisco Systems, Inc. on the deal. Cisco Systems, Inc. (NASDAQ: CSCO), a worldwide leader in technology that powers the internet, announced its […]